It’s been a good week for Jenoptik AG (ETR:JEN) shareholders, because the company has just released its latest quarterly results, and the shares gained 7.3% to €41.98. Jenoptik missed revenue estimates by 4.4%, coming in at€262m, although statutory earnings per share (EPS) of €0.40 beat expectations, coming in 3.6% ahead of analyst estimates. Earnings are an important time for investors, as they can track a company’s performance, look at what the analysts are forecasting for next year, and see if there’s been a change in sentiment towards the company. Readers will be glad to know we’ve aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Jenoptik after the latest results.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.
Following the latest results, Jenoptik’s nine analysts are now forecasting revenues of €1.13b in 2026. This would be an okay 7.6% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to ascend 18% to €1.79. Before this earnings report, the analysts had been forecasting revenues of €1.13b and earnings per share (EPS) of €1.76 in 2026. So it’s pretty clear that, although the analysts have updated their estimates, there’s been no major change in expectations for the business following the latest results.
Check out our latest analysis for Jenoptik
It will come as no surprise then, to learn that the consensus price target is largely unchanged at €45.31. That’s not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Jenoptik, with the most bullish analyst valuing it at €56.00 and the most bearish at €29.50 per share. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Jenoptik shareholders.
Of course, another way to look at these forecasts is to place them into context against the industry itself. It’s clear from the latest estimates that Jenoptik’s rate of growth is expected to accelerate meaningfully, with the forecast 16% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 8.1% p.a. over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 10% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Jenoptik to grow faster than the wider industry.
The Bottom Line
The most obvious conclusion is that there’s been no major change in the business’ prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. The consensus price target held steady at €45.31, with the latest estimates not enough to have an impact on their price targets.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year’s earnings. At Simply Wall St, we have a full range of analyst estimates for Jenoptik going out to 2028, and you can see them free on our platform here..
It might also be worth considering whether Jenoptik’s debt load is appropriate, using our debt analysis tools on the Simply Wall St platform, here.
New:Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks
Have feedback on this article? Concerned about the content?Get in touchwith us directly.Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Micron (MU) is booming, and it still doesn’t look ‘expensive’ based on next year’s earnings. So why does our own valuation say it could be worth 40% less?
A low price to earnings ratio at the top of the cycle is a warning rather than a bargain, and a terrifyingly high one at the bottom is often the entry point
Memory used to have a dozen participants racing each other into oversupply, and now it has three. High bandwidth memory is qualified into customer designs years ahead, sold under long-term agreements, and is far harder to switch away from than commodity DRAM.
About XTRA:JEN
Jenoptik
Provides advanced photonic solutions and smart mobility solutions in Germany and internationally.
Solid track record with excellent balance sheet.
Similar Companies
Market Insights
Picking portfolio winners takes more than hot airAndrew Legget
What Korea’s market says about your index fundMitchell Lawler
What does frontier-beating open
Weekly Picks
Rick_Orfordon Starfighters Space·8 days ago
The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market
Fair Value:US$515.2% undervalued
27followersusers have followed this narrative
·1commentusers have commented on this narrative
·5likesusers have liked this narrative
FU
FundamentalFlowon Vertiv Holdings Co·12 days ago
The Short and Long Term Compounder of Liquid Cooling industry.
John_Ericon SPX Technologies·7 days ago
I Fell in Love With a Data-Center Cooling Stock. Then I Opened the Filings.
Fair Value:US$2037.1% overvalued
21followersusers have followed this narrative
·2commentsusers have commented on this narrative
·6likesusers have liked this narrative
TR
tripledubon GQG Partners·2 days ago
The Cheap Genius Problem
RecentlyUpdated Narratives
Conrad_Egusaon Grupo Cibest·about 6 hours ago
Why Bancolombia’s undervaluation offers investment upside
Fair Value:Col$91.69k4.0% undervalued
1followerusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
GE
GeraldBuffeton Logindo Samudramakmur·about 12 hours ago
LEAD: The Offshore Recovery Opportunity
Ontologicalon Lotus Technology·about 16 hours ago
Lotus Tech, Finloop and FOMO Pay Collaborate to Explore Vehicle Tokenization
Popular Narratives
oscargarciaon NVIDIA·2 months ago
The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
CubanEroson Microsoft·about 1 month ago
A wonderful business at reasonable price.
KiwiInveston Amazon.com·3 months ago
